- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Ehlers-Danlos Syndrome Type 6
Total 3237 results
-
Maxinovel Pty., Ltd.RecruitingAcute Myeloid Leukemia | Leukemia | Myelodysplastic Syndrome | Relapsed/Refractory Acute Myeloid LeukemiaChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid LeukemiaUnited States
-
Hemavant Sciences GmbHTerminatedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, ChronicKorea, Republic of, United States, Taiwan, Belgium, France, Spain, Italy
-
University of RochesterCompletedMyelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited States
-
Janssen Research & Development, LLCargenxWithdrawnMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicUnited Kingdom, Switzerland, Italy, Germany, France, Spain, Australia, Turkey, Brazil, Russian Federation, Saudi Arabia
-
CelgeneCompletedLeukemia, Myelomonocytic, Chronic | Myelodysplastic SyndromeSpain
-
University Hospital, GrenobleCompletedMyelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaFrance
-
GlaxoSmithKlineCompletedMyelodysplastic SyndromePuerto Rico, United States, Taiwan, Germany, Denmark, Hong Kong, Korea, Republic of, France, United Kingdom, Italy, Brazil
-
M.D. Anderson Cancer CenterEisai Inc.CompletedChronic Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited States
-
PfizerCompletedMyelodysplastic Syndrome | Acute Myeloid Leukemia (AML)United States
-
The First Affiliated Hospital of Soochow UniversityRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome | Allogeneic Hematopoietic Stem Cell TransplantationChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | High Risk Myelodysplastic SyndromeUnited States
-
Astellas Pharma Global Development, Inc.CompletedMyelodysplastic Syndrome | Acute Myeloid Leukemia (AML)United States, Japan
-
Cleave Therapeutics, Inc.CompletedMyelodysplastic Syndromes | Acute Myeloid Leukemia, in RelapseUnited States, Australia
-
Janssen Research & Development, LLCCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Spain, Germany
-
Carlos Graux, MD, PhDCelgene Corporation; Belgian Hematological SocietyCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaBelgium
-
Boehringer IngelheimCompletedMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicJapan
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedChronic Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited States
-
Indiana University School of MedicineBayerCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Promyelocytic, AcuteUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
M.D. Anderson Cancer CenterEisai Inc.TerminatedChronic Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited States
-
Nordic MDS GroupUnknownMyelodysplastic Syndrome | Acute Myelogenous LeukemiaSweden
-
Medical College of WisconsinRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
CelgeneCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteCanada, Spain, United Kingdom, United States, France, Austria, Germany, Italy, Netherlands, Belgium, Portugal, Poland
-
Maastricht University Medical CenterMaastricht UniversityCompleted
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Radboud University Medical CenterUnknownMyotonic Dystrophy Type 2 | McArdle Disease | Nemaline Myopathy Type 6
-
Stanford UniversityCompletedMyelodysplastic Syndromes | Leukemia | Myeloproliferative Disorders | Acute Disease | Myelodysplastic Syndromes (MDS) | Leukemia, Myeloid, Chronic | Blood and Marrow Transplant (BMT)United States
-
National Taiwan University HospitalRecruitingAutoimmune Polyendocrine Syndrome Type IITaiwan
-
Laura TosiChildren's National Research Institute; Ultragenyx Pharmaceutical IncActive, not recruitingCutaneous Skeletal Hypophosphatemia Syndrome (CSHS) | Epidermal Nevus SyndromeUnited States
-
Merck Sharp & Dohme LLCCompletedMyelodysplastic Syndromes | Anemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndromes (MDS) | Chronic Myelomonocytic Leukemia (CMML) | Low to Intermediate-1 MDSUnited States, France
-
Everett MeyerCompletedLeukemia, Myeloid | Myeloproliferative Disorders | Anemia | Neural Tube Defects | Myelodysplastic Syndromes (MDS) | Bone Marrow Transplant FailureUnited States
-
La Jolla Pharmaceutical CompanyTerminatedHepatorenal Syndrome Type I and Type IIUnited States
-
Duke UniversityKriya TherapeuticsRecruitingGlycogen Storage Disease VI | GLYCOGEN STORAGE DISEASE IXa1 | GLYCOGEN STORAGE DISEASE IXa2 | Glycogen Storage Disease IXB | Glycogen Storage Disease IXC | GSD 9 (All Subtypes) | GSD 6United States
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingRecurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Recurrent Myeloproliferative NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.RecruitingRecurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic Syndrome | Therapy-Related Myelodysplastic SyndromeUnited States
-
Johns Hopkins UniversityVascular Birthmarks FoundationCompletedEpilepsy | Sturge Weber SyndromeUnited States
-
University of British ColumbiaUltragenyx Pharmaceutical IncUnknownGlucose Transporter Type 1 Deficiency SyndromeCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Blasts More Than 10 Percent of Bone Marrow Nucleated CellsUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Acute Myeloid Leukemia Post Cytotoxic TherapyUnited States
-
Clinica Universidad de Navarra, Universidad de...Completed
-
University of California, IrvineMainz UniversityCompletedSturge - Weber Syndrome (SWS)United States
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Secondary Myelodysplastic SyndromeUnited States
-
Ascentage Pharma Group Inc.RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | AML | MDS | CMML | High-risk Myelodysplastic SyndromeUnited States
-
Astex Pharmaceuticals, Inc.RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelocytic Leukemia | Myelodysplastic Syndrome/NeoplasmUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteJapan, Taiwan, Korea, Republic of
-
The Eye Center and The Eye Foundation for Research...CompletedAutoimmune Polyglandular Syndrome Type I | Autoimmune Keratitis
-
AmgenCompletedChronic Myelomonocytic Leukemia | Higher Risk Myelodysplastic SyndromeUnited States